Resources Library

GET RESOURCE

Please provide the requested details below to download the document.

ACCEPTABILITY OF IMPLANTABLE CGM (EUROPE) – 2017

Acceptability of Implantable Continuous Glucose Monitoring Sensor

This European study included 51 participants with Type 1 and Type 2 diabetes. It showed that the Eversense CGM with under-the-skin sensor was widely accepted by users and favorably evaluated by a high percentage of participants in the study.

Related Resources

Infographic
EVERSENSE AT A GLANCE

Check out this graphic overview of the…

Interactive Module
FUNDAMENTALS OF CGM

Learn more about how continuous glucose…

Video
HOW TO GET STARTED

Get started with your new Eversense 90-day,…